Spectaire (SPEC) Competitors $0.0003 0.00 (0.00%) As of 08/14/2025 09:30 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsTrendsBuy This Stock SPEC vs. THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, VLTO, and TERShould you be buying Spectaire stock or one of its competitors? The main competitors of Spectaire include ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), Veralto (VLTO), and Teradyne (TER). These companies are all part of the "measuring and control equipment" industry. Spectaire vs. Its Competitors ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Veralto Teradyne Spectaire (NASDAQ:SPEC) and ThermoGenesis (NASDAQ:THMO) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings. Do insiders & institutionals have more ownership in SPEC or THMO? 26.5% of Spectaire shares are owned by institutional investors. Comparatively, 5.8% of ThermoGenesis shares are owned by institutional investors. 25.4% of Spectaire shares are owned by company insiders. Comparatively, 78.0% of ThermoGenesis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher earnings & valuation, SPEC or THMO? Spectaire has higher earnings, but lower revenue than ThermoGenesis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpectaireN/AN/A$8.95MN/AN/AThermoGenesis$9.61M0.00-$17.98M-$5.140.00 Does the media refer more to SPEC or THMO? In the previous week, Spectaire's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score. Company Overall Sentiment Spectaire Neutral ThermoGenesis Neutral Which has more volatility and risk, SPEC or THMO? Spectaire has a beta of -6.38, meaning that its stock price is 738% less volatile than the S&P 500. Comparatively, ThermoGenesis has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Is SPEC or THMO more profitable? ThermoGenesis' return on equity of 0.00% beat Spectaire's return on equity.Company Net Margins Return on Equity Return on Assets SpectaireN/A -81.22% 304.57% ThermoGenesis N/A N/A N/A SummaryThermoGenesis beats Spectaire on 4 of the 7 factors compared between the two stocks. Get Spectaire News Delivered to You Automatically Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SPEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPEC vs. The Competition Export to ExcelMetricSpectaireMeasuring & controlling devices IndustryComputer SectorNASDAQ ExchangeMarket Cap$6K$32.58M$29.98B$9.82BDividend YieldN/A8.70%3.10%4.08%P/E RatioN/A4.0151.5525.12Price / SalesN/A3.151,328.98116.42Price / CashN/A8.3836.2759.05Price / Book0.001.719.486.18Net Income$8.95M$7.16M$803.97M$264.89M7 Day PerformanceN/A4.64%1.00%4.22%1 Month PerformanceN/A-4.29%0.15%2.02%1 Year PerformanceN/A-10.78%23,893.80%24.22% Spectaire Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPECSpectaireN/A$0.00flatN/A-99.6%$6KN/A0.008THMOThermoGenesisN/AN/AN/A-99.9%$1K$9.61M0.0040HTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.08-6.1%N/A-47.8%$0.00N/A0.003PRENWPrenetics GlobalN/A$0.03-12.7%N/A+113.4%$0.00$41.52M0.001Positive NewsShort Interest ↑Gap DownHigh Trading VolumeQSIAWQuantum-SiN/A$0.33-12.0%N/A+157.2%$0.00$3.41M0.00150Positive NewsShort Interest ↓Gap DownSMAPWSportsMap Tech AcquisitionN/A$0.03-3.1%N/AN/A$0.00N/A0.00N/AGap DownTTTrane Technologies4.3385 of 5 stars$435.30-0.8%$458.60+5.4%+21.7%$97.67B$19.84B34.5245,000Positive NewsKEYSKeysight Technologies4.2766 of 5 stars$170.38+2.0%$187.50+10.0%+23.1%$28.76B$4.98B40.0015,500Positive NewsUpcoming EarningsVLTOVeralto2.569 of 5 stars$109.66+0.8%$113.43+3.4%-1.7%$27.00B$5.19B30.6317,000Positive NewsTERTeradyne4.5416 of 5 stars$114.01+2.1%$114.44+0.4%-16.9%$17.76B$2.83B39.456,500Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies THMO Alternatives HTGMQ Alternatives OLITW Alternatives PRENW Alternatives QSIAW Alternatives SMAPW Alternatives TT Alternatives KEYS Alternatives VLTO Alternatives TER Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SPEC) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectaire Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectaire With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access